Home -> Law Blog Directory -> Academic Blogs -> Legal Theory Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Academic
: Legal Theory BlogHo on Competing Patent Perspectives
By Lawrence Solum
-
This article takes a fresh approach to better understand charged discussions concerning the proper balance of patents and public health.
The basic thesis is that while there is a spectrum of views on patents, they are benchmarked by two distinct and seemingly irreconcilable perspectives. One perspective views patents as a mere privilege granted by a nation and thus inherently subject to limitations to accommodate other societal goals, such as access to medicine. The other perspective views patents as an 'uber-right' in that the property right granted by the patent is seen as stronger than traditional property rights that tend to have limitations. While each view may be generally consistent with prior categories of rights- maximalist or rights-minimalist approaches, this article argues instead that neither is per se correct, and that the more important issue is the impact each view has on how patent rules, including rules under TRIPS, are interpreted.
The recent Thai compulsory licenses of patented drugs are used to illustrate the existence and impact of the competing perspectives. The analysis shows that competing perspectives may result in substantial distortions of the law inconsistent with appropriate legal analysis - even by lawyers. The article also considers how the perspectives may be useful in providing a richer understanding of the history of TRIPS, as well as current conflicts. The article concludes with an explanation of how such perspectives are consistent with lessons from social cognition research and that further exploration of such research may help attain the thus-far elusive goal of abating tensions between patents and public health.
Full post as published by Legal Theory Blog on April 26, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Perspectives on legal research and writing
Catholic Perspectives on Law course at Oklahoma
US Judge: US Patent Law Destabilising; Right To Patent Under Attack
Attack on Academic Freedom at York U/Toronto Continues
Professional Reading: Critical Perspectives on Web 2.0
The End Is Near Senate Committee Votes On Patent Reform









